NIAID Site Search

Jordan Report: Accelerated Development of Vaccines (2012) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2012

Expert articles from Jordan Report: Accelerated Development of Vaccines (2012) from NIAID

Last Reviewed: December 31, 2012

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

2012 update from NIAID on vaccine research for specific infectious diseases including Dengue, SARS, West Nile Virus, HIV/AIDS, and others

Last Reviewed: January 1, 2013

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Nico Contreras, Ph.D., of University of Arizona, F31 sample application

Last Reviewed: March 31, 2025

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Last Reviewed: November 24, 2023

Last Reviewed: November 24, 2023

Publications going back to 2020 by scientists working with the NIH Center for Human Immunology, Inflammation, and Autoimmunity, including links.

Last Reviewed: September 10, 2024

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Development of diagnostics tools to detect exposure to pathogens, insects, and ticks The host immune response to insect-borne pathogens Pathogen-insect interactions Field expertise in epidemiology and pathogen transmission of insect-borne diseases

Last Reviewed: February 26, 2025

Michael Lenardo, M.D., is the Former Chief of the Molecular Development of the Immune System Section and the Former Co-Director, NIAID Clinical Genomics Program.

Last Reviewed: July 1, 2024

Vincent Munster, Ph.D., is the Chief of the Virus Ecology Unit. The main objectives of our research program aim to identify the underlying biotic or abiotic changes in virus-host ecology that allow these emerging viral pathogens to cross the species barrier. Recognizing both the strengths and weaknesses of a unilateral focus on field research on one hand and experimental research on the other, we set out to combine the best of both approaches in one research program, where we aim to identify drivers of cross-species transmission from data gathered in the field and model these drivers under experimental conditions in the lab.

Last Reviewed: February 19, 2025

TBRS is a multidisciplinary group composed of chemists, microbiologists, veterinarians, imaging scientists, and clinicians with a shared objective of improving chemotherapy for tuberculosis (TB) patients. Projects span chemical biology, medicinal chemistry, host-pathogen interactions, animal models of experimental chemotherapy, and experimental medicine clinical studies in TB patients.

Last Reviewed: March 11, 2025